Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Is Bristol-Myers Squibb Stock Outperforming the Nasdaq?

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in developing life-saving therapies across oncology, immunology, cardiovascular, and hematology, Bristol-Myers Squibb plays a critical role in advancing healthcare, improving patient outcomes, and driving medical progress worldwide.

Companies worth $10 billion or more are described as “large-cap stocks,” Bristol-Myers Squibb fits this category. As a global biopharma leader, Bristol-Myers Squibb focuses on discovering, developing, and delivering innovative medicines that address serious diseases. With a robust portfolio of life-saving therapies and a presence in markets worldwide, the company has solidified its position as a key player in advancing healthcare and improving patient outcomes globally.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.